Improving the understanding of originator and biosimilar biologics among healthcare providers in Saudi Arabia

The loss of patentability of many originator biologics has led to the rapid introduction of biosimilar agents. The anticipated economic benefit of introducing such agent has been accompanied by vagueness surrounding their biotechnology, approval requirements, positioning in treatment paradigms and p...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Saudi Pharm J
Main Authors: Omair, Mohammed A., Alhawassi, Tariq, Alwaihibi, Munira, Aldrees, Ghada, Mosli, Mahmoud, Asser, Wesam M., Alharaibi, Maryam A., Alotaibi, Atheer T., Bintaleb, Doaa A., Alharbi, Najah K., Alotaibi, Ahmed Z., Alshammari, Wajed A., Alanazi, Nouf, Asiri, Ali M., Almadany, Rana, Al Rayes, Hanan, Al-Thunian, Turki, Alotaibi, Moureq, Al Jazaeri, Abdulrazaq
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2020
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7783213/
https://ncbi.nlm.nih.gov/pubmed/33424270
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jsps.2020.11.008
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki